Schumacher JM - Search Results

1

Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.

Isacson O, Bjorklund LM, Schumacher JM. Isacson O, et al. Among authors: schumacher jm. Ann Neurol. 2003;53 Suppl 3:S135-46; discussion S146-8. doi: 10.1002/ana.10482. Ann Neurol. 2003. PMID: 12666105 Review.

2

Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.

Hallett PJ, Deleidi M, Astradsson A, Smith GA, Cooper O, Osborn TM, Sundberg M, Moore MA, Perez-Torres E, Brownell AL, Schumacher JM, Spealman RD, Isacson O. Hallett PJ, et al. Among authors: schumacher jm. Cell Stem Cell. 2015 Mar 5;16(3):269-74. doi: 10.1016/j.stem.2015.01.018. Epub 2015 Feb 26. Cell Stem Cell. 2015. PMID: 25732245 Free PMC article.

3

Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease.

Deacon T, Schumacher J, Dinsmore J, Thomas C, Palmer P, Kott S, Edge A, Penney D, Kassissieh S, Dempsey P, Isacson O. Deacon T, et al. Nat Med. 1997 Mar;3(3):350-3. doi: 10.1038/nm0397-350. Nat Med. 1997. PMID: 9055867

4

Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results.

Fink JS, Schumacher JM, Ellias SL, Palmer EP, Saint-Hilaire M, Shannon K, Penn R, Starr P, VanHorne C, Kott HS, Dempsey PK, Fischman AJ, Raineri R, Manhart C, Dinsmore J, Isacson O. Fink JS, et al. Among authors: schumacher jm. Cell Transplant. 2000 Mar-Apr;9(2):273-8. doi: 10.1177/096368970000900212. Cell Transplant. 2000. PMID: 10811399 Clinical Trial.

5

Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells.

Isacson O, Costantini L, Schumacher JM, Cicchetti F, Chung S, Kim K. Isacson O, et al. Among authors: schumacher jm. Parkinsonism Relat Disord. 2001 Jul;7(3):205-212. doi: 10.1016/s1353-8020(00)00059-6. Parkinsonism Relat Disord. 2001. PMID: 11331188

6

Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids.

Schumacher JM, Short MP, Hyman BT, Breakefield XO, Isacson O. Schumacher JM, et al. Neuroscience. 1991;45(3):561-70. doi: 10.1016/0306-4522(91)90271-o. Neuroscience. 1991. PMID: 1837849

7

Transplantation of embryonic porcine mesencephalic tissue in patients with PD.

Schumacher JM, Ellias SA, Palmer EP, Kott HS, Dinsmore J, Dempsey PK, Fischman AJ, Thomas C, Feldman RG, Kassissieh S, Raineri R, Manhart C, Penney D, Fink JS, Isacson O. Schumacher JM, et al. Neurology. 2000 Mar 14;54(5):1042-50. doi: 10.1212/wnl.54.5.1042. Neurology. 2000. PMID: 10720272 Clinical Trial.

8

Improved surgical cell therapy in Parkinson's disease. Physiological basis and new transplantation methodology.

Isacson O, van Horne C, Schumacher JM, Brownell AL. Isacson O, et al. Among authors: schumacher jm. Adv Neurol. 2001;86:447-54. Adv Neurol. 2001. PMID: 11554007 Review. No abstract available.

9

Cell-mediated delivery of neurotrophic factors and neuroprotection in the neostriatum and substantia nigra.

Isacson O, Frim DM, Galpern WR, Tatter SB, Breakefield XO, Schumacher JM. Isacson O, et al. Among authors: schumacher jm. Restor Neurol Neurosci. 1995 Jan 1;8(1):59-61. doi: 10.3233/RNN-1995-81213. Restor Neurol Neurosci. 1995. PMID: 21551807 No abstract available.

10

Neuronal xenotransplantation in Parkinson's disease.

Schumacher JM, Isacson O. Schumacher JM, et al. Nat Med. 1997 May;3(5):474-5. doi: 10.1038/nm0597-474c. Nat Med. 1997. PMID: 9142103 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results